Photoaging Treatment With Imiquimod

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

August 31, 2013

Conditions
Photoaging
Interventions
DRUG

Imiquimod

"From the group of subjects who met the inclusion criteria, 22 people were selected randomly (using a random number table) since a 20-25% loss to follow up was calculated and the least amount of patients needed were 17.~During the study participants applied imiquimod cream 5% (Virosupril ® laboratories Roemmers) in the periocular area during the night, three times a week, on nonconsecutive days, for 12 weeks (3 months). If patients presented irritative dermatitis a topical 0.05% desonide cream was administered and applied for less of 5 days until symptoms improved."

Trial Locations (1)

050021

Centro de servicios CES Sabaneta, Medellín

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CES University

OTHER

NCT01935310 - Photoaging Treatment With Imiquimod | Biotech Hunter | Biotech Hunter